ENTERA BIO LTD. (ENTX) Operating income 2020–2025
ENTERA BIO LTD. (ENTX) annual operating income history from SEC filings — each fiscal year as reported.
-$11.5MFY2025 · since FY2020: -$11.2M → -$11.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.5M | -20.3% |
| FY2024 | -$9.6M | -7.8% |
| FY2023 | -$8.9M | +31.7% |
| FY2022 | -$13.0M | -6.5% |
| FY2021 | -$12.2M | -9.4% |
| FY2020 | -$11.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ENTX financial trends
ENTX RevenueENTX Net incomeENTX Net marginENTX Gross profitENTX Gross marginENTX Operating marginENTX Operating cash flowENTX Free cash flowENTX Capital expendituresENTX Return on equityENTX Stock buybacksENTX Dividends paidENTX Total assetsENTX Total liabilitiesENTX Shareholders’ equityENTX overview →